Description
With no cure or vaccine in sight, HIV/AIDS remains a devastating epidemic, particularly in sub-Saharan Africa where nearly 70% of new HIV infections occur. To curb HIV/AIDS, researchers have proposed a strategy to use drug treatment to decrease new transmissions so much that the epidemic eventually dies out. The concept requires changes in standards of when anti-retroviral therapy begins and who receives it. Could “treatment as prevention” prove to be the strategy to finally end the AIDS epidemic?
This event was presented in Collaboration with PRI’s The World and WGBH on December 1, 2014 and is part of The Andelot Series on Current Science Controversies.
Watch the entire series from The Forum at Harvard School of Public Health at www.ForumHSPH.org.
More than 100 million Americans struggle with chronic pain, according to one Institute of Medicine estimate, at an annual cost of as much as $635 billion in treatment and lost productivity. Further, the misuse of potent opioid painkillers, while increasing risk of addiction and abuse, can confuse...
Published 11/14/16
Health care has emerged as a hotly debated issue of the 2016 presidential election, with the Republican and Democratic presidential nominees expressing starkly different views on the Affordable Care Act (ACA). While approximately 20 million people have gained healthcare coverage since the law’s...
Published 11/04/16
According to the CDC, nearly 29 million U.S. women and 16 million U.S. men have experienced severe physical violence by an intimate partner at some point in their lifetime. Most of those experiences occur before the age of twenty-five. The evidence is clear that domestic violence takes a physical...
Published 10/25/16